Cardiovascular outcomes and angiotensin converting enzyme inhibitors: beyond blood pressure control. Editorial to: "Secondary prevention of coronary disease with ACE inhibition--does blood pressure reduction with perindopril explain the benefits in EUROPA?" by Remme et al

Cardiovasc Drugs Ther. 2009 Apr;23(2):109-11. doi: 10.1007/s10557-008-6152-5. Epub 2008 Nov 13.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / pharmacology*
  • Blood Pressure / drug effects
  • Clinical Trials as Topic
  • Coronary Artery Disease / drug therapy*
  • Coronary Artery Disease / mortality
  • Coronary Artery Disease / physiopathology
  • Humans
  • Perindopril / pharmacology*
  • Treatment Outcome

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Perindopril